{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:35:16Z","timestamp":1775756116069,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T00:00:00Z","timestamp":1532736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10067-018-4242-8","type":"journal-article","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T11:59:05Z","timestamp":1532779145000},"page":"3419-3425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?"],"prefix":"10.1007","volume":"37","author":[{"given":"D\u00f6nd\u00fc \u00dcsk\u00fcdar","family":"Cansu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hava \u00dcsk\u00fcdar","family":"Teke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdal","family":"Bodak\u00e7i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cengiz","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,28]]},"reference":[{"key":"4242_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/1573397112666160824151801","volume":"12","author":"AN Malaviya","year":"2016","unstructured":"Malaviya AN (2016) Low-dose methotrexate (LD-MTX) in rheumatology practice - a most widely misunderstood drug. Curr Rheumatol Rev 12:168\u2013176","journal-title":"Curr Rheumatol Rev"},{"issue":"Suppl 12","key":"4242_CR2","first-page":"35","volume":"12","author":"ME Weinblatt","year":"1985","unstructured":"Weinblatt ME (1985) Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol Suppl 12(Suppl 12):35\u201339","journal-title":"J Rheumatol Suppl"},{"key":"4242_CR3","unstructured":"James R (2005). Methotrexate, leflunomaide and combination therapies. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge C. (ed). Kelley\u2019s Textbook.7th edn. Elsevier, Philadelphia, pp 900-919"},{"key":"4242_CR4","first-page":"2299","volume":"24","author":"Y Ohosone","year":"1997","unstructured":"Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Mimori T, Akizuki M, Ikeda Y (1997) Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis. J Rheumatol 24:2299\u20132303","journal-title":"J Rheumatol"},{"issue":"2","key":"4242_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/art.1780390214","volume":"39","author":"Sergio Gutierrez-Ure\u00f1a","year":"1996","unstructured":"Gutierrez-Ure\u00f1a S, Molina JF, Garc\u00eda CO, Cu\u00e9llar ML, Espinoza LR (1996). Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 39:272\u20136","journal-title":"Arthritis & Rheumatism"},{"issue":"1","key":"4242_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5152\/tftrd.2014.27870","volume":"60","author":"Haya Uskudar","year":"2014","unstructured":"Teke HU, \u00d6zen M (2014). Low-dose methotrexate induces pancytopenia in rheumatoid arthritis patients: are the risk factors predictors for physicians? Turk J Phys Med Rehab 60:54\u20137","journal-title":"T\u00fcrkiye Fiziksel Tip ve Rehabilitasyon Dergisi"},{"issue":"1","key":"4242_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10067-006-0301-7","volume":"26","author":"Yogesh Preet Singh","year":"2006","unstructured":"Preet Singh Y, Aggarwal A, Misra R, Agarwal V (2007). Low-dose methotrexate-induced pancytopenia.Clin Rheumatol 26:84-7","journal-title":"Clinical Rheumatology"},{"key":"4242_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0049-0172(85)90029-0","volume":"15","author":"SK MacKinnon","year":"1985","unstructured":"MacKinnon SK, Starkebaum G, Willkens RF (1985) Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 15:119\u2013126","journal-title":"Semin Arthritis Rheum"},{"key":"4242_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00124743-200102000-00005","volume":"7","author":"KH Yoon","year":"2001","unstructured":"Yoon KH, Ng SC (2001) Early onset methotrexate-induced pancytopenia and response to G-CSF: a report of two cases. J Clin Rheumatol 7:17\u201320","journal-title":"J Clin Rheumatol"},{"key":"4242_CR10","first-page":"679580","volume":"2014","author":"F Gonzalez-Ibarra","year":"2014","unstructured":"Gonzalez-Ibarra F, Eivaz-Mohammadi S, Surapaneni S, Alsaadi H, Syed AK, Badin S, Marian V, Elamir M (2014) Methotrexate induced pancytopenia. Case Rep Rheumatol 2014:679580","journal-title":"Case Rep Rheumatol"},{"key":"4242_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/1756-185X.13004","volume":"20","author":"S Ajmani","year":"2017","unstructured":"Ajmani S, Preet Singh Y, Prasad S, Chowdhury A, Aggarwal A, Lawrence A, Misra R, Mishra R, Agarwal V (2017) Methotrexate-induced pancytopenia: a case series of 46 patients. Int J Rheum Dis 20:846\u2013851","journal-title":"Int J Rheum Dis"},{"key":"4242_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/rheumatology\/keh685","volume":"44","author":"AY Lim","year":"2005","unstructured":"Lim AY, Gaffney K, Scott DG (2005) Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years. Rheumatology (Oxford) 44:1051\u20131055","journal-title":"Rheumatology (Oxford)"},{"key":"4242_CR13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.autrev.2014.08.027","volume":"13","author":"S Kivity","year":"2014","unstructured":"Kivity S, Zafrir Y, Loebstein R, Pauzner R, Mouallem M, Mayan H (2014) Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients. Autoimmun Rev 13:1109\u20131113","journal-title":"Autoimmun Rev"},{"key":"4242_CR14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1345\/aph.1A052","volume":"35","author":"JM Calvo-Romero","year":"2001","unstructured":"Calvo-Romero JM (2001) Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis. Ann Pharmacother 35:1575\u20131577","journal-title":"Ann Pharmacother"},{"key":"4242_CR15","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsk\u00fd J, Wolfe F, Hawker G (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"4242_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/ard.2003.016337","volume":"63","author":"Y Berkun","year":"2004","unstructured":"Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Abou Atta I, Mevorach D, Friedman G, Ben-Yehuda A (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63:1227\u20131231","journal-title":"Ann Rheum Dis"},{"key":"4242_CR17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD (2016) Preventing and managing toxicities of high-dose methotrexate. Oncologist 21:1471\u20131482","journal-title":"Oncologist"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4242-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4242-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4242-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T19:19:45Z","timestamp":1564255185000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4242-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,28]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4242"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4242-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,28]]},"assertion":[{"value":"21 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study has been approved by the local ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}